the aid library

Filter

9269

Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries

Bazargani, Y.T.; Ugurlu, M.; Leufkens, H.G.M. et al. BMC Cardiovascular Disorders (2018) CC

The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of ... more

Download

View PDF

The use of rectal artesunate as a pre-referral treatment for severe P. falciparum malaria

World Health Organization WHO (2023) C_WHO

Information note. In 2021, preliminary results of observational studies from the Community Access to Rectal Artesunate for Malaria (CARAMAL) project did not confirm the mortality impact observed in ... more

Download

View PDF

Best Buys to Accelerate Disease Elimination in the Americas

Pan American Health Organization PAHO (2025) C_WHO

The Best Buys for Disease Elimination is a practical, evidence-based guide to the most effective actions for countries to implement in order to eli ... more

External Link

Retention and mortality outcomes from a community-supported public–private HIV treatment programme in Myanmar

Mburu, Gitau; Aung Zayar Paing; Nwe Ni Myint et al. (2016) CC

Journal of the International AIDS Society 2016, 19:20926
There is a growing interest in the potential contribution the private sector can make towards increasing access to antiretroviral therap ... more

External Link

Cholera: Clinical features, diagnosis, treatment, and prevention

LaRocque, R.; S.B. Calderwood and A.Bloom UpToDate (2020) C1

The document provides a detailed overview of cholera, including its clinical features, diagnosis, treatment, and prevention. It explains the causes of cholera, its symptoms such as severe diarrhea and dehydration, and the importance of rehydration t ... more

Download

View PDF

Implementation Framework & Clinical Guidance for Viral Hepatitis Prevention & Treatment 2019

Ministry of Health, Zambia (2020) CC

The Zambia Population Based HIV impact assessment of 2016, reported the prevalence of viral hepatitis in Zambia as ranging between 5.6% among adults aged 15 to 59% in the general population, and 7.1% among HIV infected individuals. It is estimated t ... more

Download

View PDF

Recommended package of interventions for HIV, viral hepatis and STI prevention, diagnosis, treatment and care for people who inject drugs: policy brief

World Health Organisation (WHO) (2023) C_WHO

HIV, viral hepatitis and STI epidemics, particularly among people who inject drugs and other key populations, continue to be fuelled by laws and policies criminalizing sex work; drug use or possession; diverse forms of gender expression and sexualit ... more

Download

View PDF

How to support survivors of gender-based violence when a GBV actor is not available in your area

Inter-Agency Standing Committee (2023) CC

KEY MESSAGES Always talk to a GBV specialist first to understand what GBV services are available in your area. Some services may take the form of hotlines, a mobile app or other remote support. ... Be aware of any other available services in your area. Identify services provided by humanitarian partners such as health, psychosocial support, shelter and non-food items. Consider services provided by communities such as mosques/ churches, women’s groups and Disability Service Organizations. Remember your role. Provide a listening ear, free of judgment. Provide accurate, up-to-date information on available services. Let the survivor make their own choices. Know what you can and cannot manage. Even without a GBV actor in your area, there may be other partners, such as a child protection or mental health specialist, who can support survivors that require additional attention and support. Ask the survivor for permission before connecting them to anyone else. Do not force the survivor if s/he says no. Do not proactively identify or seek out GBV survivors. Be available in case someone asks for support. Remember your mandate. All humanitarian practitioners are mandated to provide non-judgmental and non-discriminatory support to people in need regardless of: gender, sexual orientation, gender identity, marital status, disability status, age, ethnicity/tribe/race/religion, who perpetrated/committed violence, and the situation in which violence was committed. Use a survivor-centered approach by practicing: Respect: all actions you take are guided by respect for the survivor’s choices, wishes, rights and dignity. Safety: the safety of the survivor is the number one priority. Confidentiality: people have the right to choose to whom they will or will not tell their story. Maintaining confidentiality means not sharing any information to anyone. Non-discrimination: providing equal and fair treatment to anyone in need of support. If health services exist, always provide information on what is available. Share what you know, and most importantly explain what you do not. Let the survivor decide if s/he wants to access them. Receiving quality medical care within 72 hours can prevent transmission of sexually transmitted infections (STIs), and within 120 hours can prevent unwanted pregnancy. Provide the opportunity for people with disabilities to communicate to you without the presence of their caregiver, if wished and does not endanger or create tension in that relationship. If a man or boy is raped it does not mean he is gay or bisexual. Gender-based violence is based on power, not someone’s sexuality. Sexual and gender minorities are often at increased risk of harm and violence due to their sexual orientation and/or gender identity. Actively listen and seek to support all survivors. Anyone can commit an act of gender-based violence including a spouse, intimate partner, family member, caregiver, in-law, stranger, parent or someone who is exchanging money or goods for a sexual act. Anyone can be a survivor of gender-based violence – this includes, but isn’t limited to, people who are married, elderly individuals or people who engage in sex work. Protect the identity and safety of a survivor. Do not write down, take pictures or verbally share any personal/identifying information about a survivor or their experience, including with your supervisor. Put phones and computers away to avoid concern that a survivor’s voice is being recorded. Personal/identifying information includes the survivor’s name, perpetrator(s) name, date of birth, registration number, home address, work address, location where their children go to school, the exact time and place the incident took place etc. Share general, non-identifying information To your team or sector partners in an effort to make your program safer. To your support network when seeking self-care and encouragement. more

External Link

Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis

Krentel, A.; Gyapong, M.; McFarland, D.A.; Ogundahunsi, O.; Titaley, C.R.; Addiss, D.G. Oxford Academic - International Health (2021) CC

Since the launch of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) in 2000, more than 910 million people have received preventive chemotherapy for lymphatic filariasis (LF) and many thousands have received care for chronic manifestat ... more

External Link

Access to Cancer Therapeutics in Low- and Middle-Income Countries

Ruff, P.; Sana-Al-Sukhun, C. Blanchard, et al. (2016) C2

2016 ASCO EDUCATIONAL BOOK | asco.org/edbo

Download

View PDF

Report of Access to COVID-19 Tools Accelerator Facilitation Council Working Group on Diagnostics and Therapeutics

World Health Organization WHO (2022) C_WHO

This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic ... more

Download

View PDF

Falling short

International Union Against Tuberculosis and Lung Disease; Treatment Action Group; msh; ec al. (2017)

Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis. Accessed in November 2017.

Download

View PDF

Monitoring the AIDS and TB Response

Treatment Action Campaign (TAC) Treatment Action Campaign (TAC) (2020) C2

Accessed: 10.03.2020 Treatment Action Campaign (TAC): Working for Access to quality Public Healthcare in South Africa since 1998

Download

View PDF

Directrices de la OMS sobre el tratamiento farmacológico del dolor persistente en niños con enfermedades médicas

World Health Organization (2012)

The Access to Controlled Medications Programme identified the development of treatment guidelines that cover the ... more

Download

View PDF

We are also dying of AIDS

Human Rights Watch (2014) C1

Barriers to HIV Services and Treatment for Persons with Disabilities in Zambia The 80-page report documents the obstacles faced by people with disabilities in both the community and healthcare sett ... more

Download

View PDF

Nigeria: The National Strategic Plan for Tuberculosis Control 2015-2020

National Tubercolis and Leprosy Control Programme, Federal Ministry of Health, Nigeria (2015) C1

Towards Universal Access to Prevention, Diagnosis and Treatment

Download

View PDF

Gaps in service Utilization and service provision: an analysis of DHS and SPA Malaria data from Malawi, Senegal, and Tanzania

C. Taylor, A. Linn, W. Wang, and H. Moussa (2018) C2

Barriers to the prompt and effective diagnosis and treatment of malaria exist at both the community and health facility level. Household surveys measure malaria case management at the population lev ... more

Download

View PDF

Adopt AWaRe: Handle antibiotics with care

World Health Organization WHO (2015) C_WHO

AWaRe – a new WHO tool to help countries improve antibiotic treatment, increase access and reduce resistance. We can reduce or even reverse antib ... more